155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

155PDTumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial

Nuciforo, P., Prat, A., Llombart, A., Fasani, R., Paré, L., Pascual, T., Oliveira, M., Martínez Jañez, N., Bermejo De Las Heras, B., Vidal, M., Pernas Simon, S., López, R., Muñoz, M., Garau, I., Manso
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx362.006
Date:
September, 2017
File:
PDF, 54 KB
english, 2017
Conversion to is in progress
Conversion to is failed